Antitrypsin Deficiency, known as AATD, is an inherited condition passed from parents to their children through their genes.
The deficiency will result in serious lung disease in adults and, at times, can also cause lung disease in young adults.
AATD is commonly misdiagnosed as chronic asthma or COPD. In fact, out of the 12 million patients diagnosed with COPD in America, approximately 1 to 3 percent likely have A1AD.
Left untreated, A1AD results in progressive destruction of lung tissue resulting in severe loss of lung function and life expectancy.
Laird Ozmon of Ozmon Law in Joliet has pioneered the fight to seek fair compensation for those patients who have been misdiagnosed and have suffered such serious lung damage.
View the full article at HeraldNews.com